GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cipher Pharmaceuticals CPH.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

13.75

+1.78%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$51.3m

FY2016FY2025

Net income

$27.8m

FY2016FY2025

Free cash flow

$30.2m

FY2016FY2025

Shareholders' equity

$126.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$51.3m$33.4m$21.2m$20.7m$21.9m$21.6m$22.5m$22.7m$40.3m$40.7m
Gross profit$33.8m$24.1m$17.1m$16.7m$18.3m$18.6m$19.5m$20.4m$38.4m$36.2m
Research and development$21,367—$139,000$98,000$88,000$129,000$396,000$561,000$394,000$561,000
Operating income$16.9m$7.8m$11.5m$12.0m$11.8m$12.2m$11.7m$5.3m$25.2m$6.9m
Net income$27.8m$11.5m$20.4m$26.6m$7.8m$4.5m$3.2m$543,000$4.4m−$39.1m
Diluted earnings per share1.070.470.801.040.290.170.120.020.16-1.45

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$156.2m$162.5m$86.0m$73.8m$51.7m$44.3m$46.5m$55.7m$63.1m$77.4m
Cash and short-term investments$7.5m$17.8m$39.8m$28.8m$20.5m$9.1m$6.3m$10.4m$28.2m$34.5m
Total liabilities$30.2m$60.2m$5.5m$9.7m$12.8m$11.6m$18.4m$30.9m$40.2m$59.4m
Debt$5.5m$40.6m$353,000$428,000$516,000$1.8m$9.6m$17.7m$18.8m$73.9m
Shareholders' equity$126.0m$102.3m$80.5m$64.1m$38.9m$32.6m$28.0m$24.8m$22.9m$18.0m
Shares outstanding26m25m26m26m27m27m27m27m27m27m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$30.2m$19.5m$16.0m$10.6m$13.8m$11.7m$8.9m$11.3m$19.9m$11.5m
Capital spending−$28,486−$44,000−$144,000−$81,000−$81,000−$760,000−$1.3m−$6.6m−$202,000−$632,000
Free cash flow$30.2m$19.5m$15.9m$10.5m$13.7m$10.9m$7.5m$4.7m$19.7m$10.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$11.8m$12.3m$12.4m$12.8m$13.4m$12.0m$11.8m$10.4m
Gross profit$7.7m$8.4m$8.2m$10.5m$10.9m$9.1m$6.7m$8.4m
Operating income$4.4m$5.5m$2.5m$5.0m$5.0m$2.5m$334,000$3.8m
Net income$3.9m$6.1m$13.5m$5.5m$5.9m$2.6m$3.3m$283,000
Diluted earnings per share0.150.230.520.210.230.100.140.01
Cash from operations$2.0m$4.0m$8.0m$10.0m$6.0m$4.0m$8.0m$2.0m
Total assets$156.6m$153.4m$156.2m$147.5m$152.4m$163.1m$162.5m$153.9m
Cash and short-term investments$9.1m$6.4m$7.5m$8.4m$11.3m$22.0m$17.8m$9.5m
Debt$241,606$263,000$5.8m$13.4m$25.5m$40.5m$40.6m$40.8m
Shareholders' equity$137.0m$132.8m$126.0m$113.9m$109.4m$105.2m$102.3m$98.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue35.4%18.9%4.1%
Operating income11.9%6.7%—
Net income1.4%43.6%31.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin68.3%72.4%75.5%83.1%
Operating margin29.2%38.2%42.5%36.7%
Net margin46.5%68.3%58.0%21.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings10.322.35.12.74.54.0
Price to sales5.67.74.93.51.60.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.